1Greenberg PL. The myelodysplastic syndromes. In: Hoffinan R,Benz E, Shattil S, et al, eds. Hematology: Basic principles and Practice[M]. 3rd ed. New York, NY: Churchill Livingstone,2000,1106 - 1129. Chinese
2Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes [ J ]. Br J Haematol,1982, 51:189 -199.
3ZHANG ZN, SHEN TI. Diagnosis of hemal disease and its curative effect standard[ J]. Publishing Company of Science, 1998:258-267. Chinese
4Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the clinical advisory committee meeting[M]. Airlie House, Virginia, November 1997. Modem Pathology, 2000,13:193 - 207.
5Bennett J. The World Health Organization (WHO) classificatiom of acute Leukemias and the myelodysplastic syndromes[M]. Iht J Hematol 2000,72:131 - 133.
6Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes[M]. Hematology,2002,136- 161.
7Germing U, Gattermann N, Strupp C, et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndrome: a retrospective analysis of 1600 patients[M]. Leuk Res,2000, 24:983-992.
8Nosslinger T, Reisner R, Koller E, et al. Myelodysplastic syndromes, from French - American - British to World Health Orgamzation: Comparison of classifications on 431 unselected patients from a single institution[ M]. Blood,2001,98:2935 -2941
同被引文献8
1GIANNOULI S, VOULGARELIS M, ZINTZARASL E, et al. Autoimmune phenomena in myelodysplastie syndromes: a 4-year prospective study[J]. Rheumatology, 2004, 43(5): 626-632.
2MALCOVATI L, GERMING U, KUENDGEN A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes[J]. J Clin Ohcol, 2007, 25(23): 3503-3510.
3CHOI JH, AHN M J, PARK YW, et al. A case of erythema nodosum and serositis associated with myelodysplasfic syndrome[J]. Korean J Intern Med, 2005, 20(2): 177-179.
4BORUCHOV AM. Thrombocytopenia in myelodysplasfie syndromes and myelofibrosis [J]. Semin Hemalol, 2009,'46 (1 Suppl 2): S37-43.
5GIAGOUNIDIS AA, HAASE S, GERMING U, et al. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion[J]. Acta Haematol, 2005, 113(2): 145-1,19.
6BOUALI F, BERRAH A, SI AHMED-BOUALI D, et al. Immunological abnormalities in myelodysplastic syndromes prospective study (series of 40 patients)[J]. Rev Med Interne, 2005, 26 (10): 777-783.
7MORAND JJ, LIGHTBURN E, RICHARD MA, et al. Skin manifestations associated with myelodysplastic syndromes[J]. Rev Med Interne, 2001, 22(9): 845-853.
